March 22, 2023
A New York federal court has awarded $10 million to Aquavit Pharmaceuticals in its lawsuit accusing South Korean competitors of making counterfeits of its Aquagold micro-injection devices, following the rivals' repeated failures to comply with an injunction and pay sanctions.